From freckles to a calmer complexion
BroadBand Light formed part of a measured plan for surface pigment, sun spots and background redness.
View the BBL case studyFreckles, sun spots, post-acne marks and melasma can all look brown, but they do not respond to treatment in the same way.
Medical Aesthetics 360 assesses the pigment pattern, skin tone, recent sun exposure and history of rebound before choosing Sciton BBL, Pico laser, nanosecond laser, LaseMD, skincare or a staged combination. The aim is visible improvement without adding unnecessary heat or inflammation.
These examples show why treatment is matched to the pigment pattern. Open any case study to read about the concern, treatment approach and individual outcome.
BroadBand Light formed part of a measured plan for surface pigment, sun spots and background redness.
View the BBL case study
This case used a staged picosecond approach for discrete facial pigmentation rather than treating every brown area as melasma.
View the PicoSure case study
A long-term pigment plan focused on gradual change and avoided presenting a single aggressive procedure as a permanent cure.
View the persistent melasma case
The treatment pathway used pigment-focused laser cautiously, with attention to skin response and maintenance.
View the even-tone case study
BBL was used within a broader skin plan for visible redness, blotchiness and marks left after breakouts.
View the redness case studyCase studies show individual outcomes, not guaranteed results. Lighting, angle, baseline pigment, treatment combination and follow-up interval can differ between cases.
A brown mark can represent superficial pigment, deeper dermal pigment, vascular change beneath pigment or a lesion that should not be treated cosmetically. Melasma may also contain mixed depths and can be influenced by hormones, heat and visible light.
Assessment considers when the pigment appeared, whether it changes with the seasons or pregnancy, how previous treatments behaved and whether the skin is currently tanned, inflamed or barrier-impaired.
Important: a new, changing, irregular, asymmetrical or bleeding pigmented lesion needs medical assessment before BBL or laser. Cosmetic light treatment should never be used to bypass diagnosis.
The most persuasive device name is not always the most appropriate treatment. Each platform has a different role, and some skin should be prepared before any energy-based procedure.
BBL is an intense pulsed light platform rather than a laser. Filters select bands of light for suitable superficial brown pigment and vascular redness. It can be useful when sun spots and blotchy redness occur together, but conservative selection matters in melanin-rich or melasma-prone skin.
Short laser pulses can target selected pigment more precisely. Wavelength, pulse structure, spot size and endpoint are chosen for the lesion and skin tone. Picosecond treatment is not automatically safer for melasma, and post-inflammatory pigmentation remains possible.
A 1927 nm fractional treatment may suit diffuse superficial photodamage and texture when broader renewal is desired. Recovery increases with intensity, and melasma still requires conservative planning and maintenance.
Daily photoprotection, barrier support and pigment-controlling skincare may be recommended before treatment. For active melasma or PIH-prone skin, preparation can be more important than rushing into a device session.
Some patients have more than one concern: for example, solar lentigines with redness, or melasma with post-acne marks. A staged plan can use different technologies at different visits rather than stacking aggressive treatments into one appointment. The order is guided by the most reactive condition and the skin's response.
A randomized physician-blinded study of freckles and lentigines found improvement with both intense pulsed light and Q-switched alexandrite laser. The laser performed better for freckles, while IPL was favoured for lentigines when post-inflammatory pigmentation affected the laser side.
The study was small and follow-up was short, so it should not be read as proof that one device is always superior. It does illustrate the central clinical point: the type of pigment and the patient's tendency to darken after inflammation can change which trade-off is acceptable.
A suitable patient has a reasonably clear diagnosis, stable skin and realistic expectations about maintenance. The plan may change when pigment is active, the skin is tanned or a previous procedure caused rebound.
The process is adjusted to the platform, but the safest pathway begins before the device is switched on.
The pattern, depth, triggers, skin tone, medication and previous response are reviewed. Suspicious lesions are excluded from cosmetic treatment.
Sun exposure and irritating products may need to be paused. Pigment-controlling skincare can be introduced when the risk profile supports it.
Eye protection is fitted and the selected light or laser settings are delivered to the planned area. Cooling supports comfort and surface safety.
The response is assessed after healing. Further treatment is based on what changed, not an automatic package or fixed number of sessions.
After BBL, the skin may feel warm and look pink for several hours. Selected brown spots often darken before becoming dry and flaking over the following days. Targeted pigment laser can also cause swelling, crusting or a more obvious treated spot.
Melasma and PIH do not always follow this predictable spot-darkening pattern. Diffuse worsening, blistering, increasing pain or pigmentation outside the intended area needs prompt review.
Possible complications include prolonged redness, swelling, burns, blistering, infection, scarring, post-inflammatory hyperpigmentation, hypopigmentation and melasma rebound. Darker and pigment-prone skin may require more conservative settings or a different platform.
There is no single best device for every brown mark. The useful comparison is between the pigment target, the treatment mechanism and the risk of inflammation.
MA360 offers several pigment, vascular and resurfacing platforms across its Sydney clinics. This allows the treatment to be matched to freckles, solar damage, redness, melasma or post-inflammatory pigment rather than forcing every concern through one device.
A conservative recommendation may include skincare preparation, staged treatment or no procedure until the skin is stable.
Convenient for patients from Sydney's Lower North Shore and surrounding suburbs.
Accessible for patients from St George, southern Sydney and nearby areas.
These answers are general. The diagnosis, skin tone and treatment history can change the recommendation.
Pigmentation can reflect cumulative sun exposure, genetics, hormones, inflammation, medication or skin injury. Freckles, solar lentigines, melasma and post-inflammatory hyperpigmentation have different behaviour, so a useful treatment plan begins with the likely diagnosis rather than the colour alone.
Sciton BBL may improve selected freckles, solar lentigines, superficial sun damage and uneven tone. It can also address background redness when suitable filters are used. Response depends on the pigment depth, skin tone, recent sun exposure and risk of post-inflammatory pigmentation.
No. BroadBand Light is an intense pulsed light platform that emits a range of wavelengths selected with filters. A laser uses a more specific wavelength. This difference affects the targets, settings, recovery and skin types for which each platform may be appropriate.
BBL may be considered cautiously in selected melasma patterns, but it is not a universal first-line treatment or a cure. Melasma can worsen after heat and inflammation and commonly relapses, so photoprotection, pigment-controlling skincare and conservative long-term planning are central.
Heat, inflammation, ultraviolet exposure, hormones and an impaired skin barrier can stimulate pigment production. Rebound is more likely when the diagnosis is wrong, settings are too aggressive or aftercare and maintenance do not control the underlying triggers.
Post-inflammatory hyperpigmentation is darkening that follows irritation or injury, including acne, dermatitis, burns and procedures. It is more common in darker or pigment-prone skin and can be triggered by treatment itself, which is why preparation and conservative settings matter.
There are options for many skin tones, but not every device or setting is suitable for everyone. Melanin-rich skin can absorb more light energy and may have a higher risk of burns or pigment change. The platform and protocol should be selected for the individual skin tone and pigment pattern.
They are related but not identical. Freckles are strongly influenced by genetics and often darken with sun exposure, while solar lentigines are persistent sun-related spots that become more common over time. Both should be distinguished from suspicious or changing lesions before cosmetic treatment.
No. A new, changing, asymmetrical, irregular, bleeding or unusual pigmented lesion should be medically assessed before any light or laser procedure. Cosmetic treatment can obscure a lesion and should not replace appropriate diagnosis.
Sensation varies by platform, settings and treatment area. BBL is often described as brief warmth or snapping, while pigment laser can feel like quick pinpricks. Cooling and topical anaesthetic may be used when appropriate, but treatment should not be promised as pain-free.
Redness and warmth may settle within hours after a lighter treatment. Treated brown spots can darken before flaking over several days, while stronger or more targeted laser can cause swelling or crusting. Recovery depends on the platform, area, skin response and intensity.
Selected freckles or sun spots can temporarily darken as treated pigment moves toward the surface. This can be expected, but widespread worsening, blistering, increasing pain or darkening outside the intended area needs prompt advice. Do not pick or scrub the treated skin.
Makeup timing depends on how the skin responds. It should not be applied over blistered, weeping or significantly irritated skin. Use the individual aftercare advice provided for the device and setting used rather than assuming a fixed next-day rule.
Some discrete spots respond after one session, while diffuse photodamage or melasma usually needs a staged plan. The number depends on diagnosis, depth, skin tone, treatment response and how well triggers are controlled. More sessions are not automatically better.
A treated spot may clear for a long time, but new sun-related pigmentation can develop and melasma can relapse. Daily sunscreen, sun avoidance, appropriate skincare and maintenance help protect improvement, but no device can stop future UV exposure or hormonal triggers.
Treatment is commonly postponed with a recent tan, sunburn, active infection, open skin, uncontrolled dermatitis or a suspicious lesion. Pregnancy, photosensitising medicines, previous pigment complications and relevant medical conditions should be discussed during screening.
Cost varies with the diagnosis, area, chosen platform and number of sessions. A meaningful quote follows assessment because a few discrete lentigines, diffuse photodamage and melasma require very different treatment and maintenance plans.
Read more about related concerns, technologies, case studies and Medical Aesthetics 360 locations.
This page provides general information and does not replace personal medical advice. Results, recovery and complications vary. Case-study images show individual outcomes and do not guarantee the same result. Assessment is required to confirm diagnosis, suitability and an appropriate treatment plan.